Significados de decompensated hf en inglés

Conclusions: Milrinone may have a bidirectional effect based on etiology in decompensated HF.

The diagnostic utility of BNP is complemented by its therapeutic use in decompensated HF.

Acute decompensated HF was classified by standardized physician review and a previously validated algorithm.

Methods and results: Thirty patients with decompensated HF were randomly assigned to diuretics or ultrafiltration.

Conclusions: Risk stratification of patients with decompensated HF may be accomplished using easily assessed clinical variables.

Conclusion: Baseline IGF-I levels may be used to predict response to levosimendan treatment in patients hospitalized for decompensated HF.

Conclusions: Elevated eNO may reflect a compensatory circulatory mechanism in HF that is lost in patients with clinically decompensated HF.

Covariate-adjusted Cox proportional hazard models were used to examine any association with future admissions for decompensated HF and total mortality.

Twenty studies presented predictors of decompensated HF, and four examined patient characteristics associated with mortality (two reported predictors of both).

Methods: We collected clinical and weight data from patients admitted with decompensated HF to a single center (2012-2013).

Objectives: The goal of this study was to assess the interaction between heart failure (HF) etiology and response to milrinone in decompensated HF.

Methods and results: OPTIME-CHF randomized 949 patients hospitalized with decompensated HF for 48 to 72 hours of infusion of either milrinone or placebo.